Humans Don’t Hibernate, but We Still Need More Winter Sleep


Summary: REM sleep is 30 minutes longer in Winter than in Summer for most people, a new study reveals.

Source: Frontiers

Whether we’re night owls or morning larks, our body clocks are set by the sun.

Theoretically, changing day length and light exposure over the course of the year could affect the duration and quality of our sleep. But figuring out how this applies in practice is difficult. Although studies where people assess their own sleep have suggested an increase in sleep duration during winter, objective measures are needed to determine how exactly the seasons affect sleep.

Scientists studying sleep difficulties have now published data in Frontiers in Neuroscience that shows that, even in an urban population experiencing disrupted sleep, humans experience longer REM sleep in winter than summer and less deep sleep in autumn.

“Possibly one of the most precious achievements in human evolution is an almost invisibility of seasonality on the behavioral level,” said Dr Dieter Kunz, corresponding author of the study, based at the Clinic of Sleep & Chronomedicine at the St Hedwig Hospital, Berlin.

“In our study we show that human sleep architecture varies substantially across seasons in an adult population living in an urban environment.”

Studying sleep

A team of scientists led by Ms Aileen Seidler in Dr Kunz’s working group at the Charité Medical University of Berlin recruited 292 patients that had undergone sleep studies called polysomnographies at the St Hedwig Hospital.

These studies are regularly carried out on patients who experience sleep-related difficulties, using a special laboratory where patients are asked to sleep naturally without an alarm clock, and the quality and type of sleep can be monitored as well as the length of sleep.

Although the sleep disorders could potentially affect the results, this makes for a large study group evenly spread throughout the year, allowing for the investigation of month-to-month differences.

The team excluded patients who were taking medications known to affect sleep, technical failures during the polysomnography, and REM sleep latency longer than 120 minutes, which suggested that the first REM sleep episode had been skipped. Once these exclusions had been made, 188 patients remained. Most of their diagnoses showed no seasonal pattern, but insomnia was more commonly diagnosed towards the end of the year.

Winter sees more REM sleep

Even though the patients were based in an urban environment with low natural light exposure and high light pollution, which should affect any seasonality regulated by light, the scientists found subtle but striking changes across the seasons. Although total sleep time appeared to be about an hour longer in the winter than the summer, this result was not statistically significant.

However, REM sleep was 30 minutes longer in the winter than in summer. REM sleep is known to be directly linked to the circadian clock, which is affected by changing light. Although the team acknowledged that these results would need to be validated in a population which experiences no sleep difficulties, the seasonal changes may be even greater in a healthy population.

This shows a woman sleeping
Although total sleep time appeared to be about an hour longer in the winter than the summer, this result was not statistically significant.

“This study needs to be replicated in a large cohort of healthy subjects,” cautioned Kunz.

Although most people’s waking time is currently largely out of their control, due to school or work schedules, society might benefit from accommodations which would allow humans to respond more effectively to the changing seasons. In the meantime, going to sleep earlier in the winter might help accommodate human seasonality.

“Seasonality is ubiquitous in any living being on this planet,” said Kunz.

“Even though we still perform unchanged, over the winter human physiology is down-regulated, with a sensation of ‘running-on-empty’ in February or March. In general, societies need to adjust sleep habits including length and timing to season, or adjust school and working schedules to seasonal sleep needs.”

Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal Cancer


Some people with colorectal cancer that can’t be removed surgically or has spread elsewhere in the body have a new treatment option. On January 19, the Food and Drug Administration (FDA) granted accelerated approval to the combination of two targeted drugs, tucatinib (Tukysa) and trastuzumab (Herceptin) for people with advanced colorectal cancer that produces an excess amount of a protein called HER2.

An illustration showing two cancer cells side by side with different amounts of HER2 on its surface.
Tucatinib (Tukysa) and trastuzumab (Herceptin) are now approved by FDA to treat some people with colorectal cancer whose tumors produce an excess of HER2 proteins. The drugs block the activity of HER2 proteins but in different ways.

To be eligible to receive the new combination, people’s tumors must also not have changes in a group of genes called RAS, and people must have previously received at least two standard treatments, including chemotherapy.

In the clinical trial that led to the accelerated approval, called MOUNTAINEER, 38% of people who received the drug combination had their tumors shrink or disappearExit Disclaimer. In another 33%, tumors stopped growing for some time. At the time the study results were presented last July, more than half the participants who received the drugs were still alive 2 years after beginning treatment.

The available treatment options for people whose metastatic colorectal cancer has returned or started growing again after receiving standard treatments are not very effective, explained John Strickler, M.D., of Duke University, who led the trial. 

“That [approach] has a response rate of less than 5%, and generally controls disease for around 2 to 4 months,” Dr. Strickler said. “So this treatment represents a fairly substantial breakthrough for patients who have HER2-positive disease” that has returned or started growing again.

HER2-positive tumors make up a small minority of colorectal cancers: only about 3% overall. Focusing on smaller and smaller groups of patients with targeted therapies can make recruiting enough people to run clinical trials challenging, said Carmen Allegra, M.D., who works with NCI’s Cancer Therapy Evaluation Program and was not involved with the study.

“But when you do find something that helps small subsets of patients, the results are often quite impressive like this,” Dr. Allegra said

Cutting off fuel for cancer cells

HER2 plays a role in normal cell growth. In many cancer types, tumor cells make extra copies of the gene that produces the HER2 protein, known as gene amplification.

The resulting flood of HER2 protein causes cancer cells to grow uncontrollably. But, on the flip side, cancer cells may also become dependent on this extra HER2 and cutting off the flow of the protein can cause them to stop growing or die.

HER2’s role is best understood in breast cancer, where up to 30% of tumors overexpress HER2 and HER2-targeted treatments are commonly used. In the last few years, researchers have discovered that HER2 is also overproduced in some stomach and esophageal cancers, Dr. Strickler said, and researchers are teasing out its contribution to other cancer types.

An image of breast cancer cells with strong HER2 amplification.

More and more, people with newly diagnosed metastatic colorectal cancer undergo certain types of gene sequencing, explained Dr. Strickler. This sequencing looks for gene changes that can be targeted with approved drugs, as well as mutations that can predict resistance to certain treatments.

“Increasingly, when we were sequencing tumors to look for mutations, we were incidentally finding HER2 amplification. But we had no FDA-approved therapies targeting HER2” for colorectal cancer, Dr. Strickler said.

He and his colleagues began a small study of two drugs targeting HER2: trastuzumab, which has been the backbone of treatment for HER2-postive breast cancer, and tucatinib, a newer drug which has proven to be particularly effective in combination with trastuzumab in breast cancer.

In studies in mice, “it had been shown repeatedly that these drugs work better when given together,” Dr. Strickler said. “Each drug by itself has modest antitumor effects in colorectal cancer, but when you give them together, the effect is what I’d call one plus one equals three.”

The team saw something similar in study participants. When they gave them only tucatinib, some people’s tumors stopped growing for a while but none shrank, and they ended up having trastuzumab added to their treatment, he explained.

Long-lasting tumor control for some people

Seagen Inc., which manufactures tucatinib, funded the team to conduct the larger MOUNTAINEER trial, which tested the combination of tucatinib and trastuzumab in 84 study participants whose advanced colorectal cancer had come back or hadn’t shrunk after previous treatments. Most participants had metastatic tumors in their liver and lungs. 

Participants also had to have genetic tests showing that their cancer didn’t have RAS mutations. Such mutations are thought to allow cancer cells to keep growing even if HER2 is blocked, rendering that treatment useless, explained Dr. Strickler.

MOUNTAINEER participants received tucatinib and trastuzumab until their cancer started growing again, or until they experienced side effects.

At the time the trial results were presented at the European Society for Medical Oncology World Congress on Gastrointestinal Cancers in 2022, participants’ tumors had continued to respond to the treatment for a median of just over a year. 

It will be important to keep following the remaining patients in the MOUNTAINEER trial for a while, said Dr. Allegra. “For those patients who did get a response, it lasted a long time, relatively speaking,” he said. “But whether that response rate will translate into a survival advantage over other treatments isn’t known yet.”

Median overall survival in the MOUNTAINEER trial was just over 2 years. In large clinical trials, said Dr. Allegra, overall survival has been about 7 months for people with advanced colorectal cancer who have already had several treatments. However, those whose tumors overexpress HER2 and don’t have RAS mutations may tend to live longer regardless of what treatment they receive, he added.

The most common side effects seen during the MOUNTAINEER trial were diarrhea, fatigue, rash, nausea, fever, and reactions to the trastuzumab infusions such as chills. The most common serious side effect was high blood pressure. Doses of tucatinib were reduced or stopped for 6% of the 84 participants due to side effects.

However, the severity and frequency of side effects with the targeted drug combination was less than that seen with the chemotherapy drugs that would normally be used for these patients, said Dr. Strickler. 

Combination therapies for longer responses?

These results of the MOUNTAINEER trial led to an ongoing follow-up study called MOUNTAINEER-03. This randomized clinical trial is testing the addition of tucatinib and trastuzumab to standard treatment regimens using chemotherapy and other targeted therapies, as initial treatment for metastatic HER2-positive colorectal cancer. 

Other trials are also testing combinations of other targeted drugs in patients with previously treated advanced colorectal cancer to see if they, like tucatinib and trastuzumab, work better when given together. 

For example, explained Dr. Allegra, another phase 3 clinical trial recently tested the combination of bevacizumab (Avastin) with trifluridine and tipiracil (Lonsurf) in people with advanced colorectal cancer who had received at least two previous treatments. Those participants lived for a median of almost a year after starting treatment. Participants in that trial could receive the study drug combination regardless of the gene mutations found in their tumors.

For people with advanced HER2-positive tumors, researchers are interested in testing other treatments that target the protein, such as trastuzumab deruxtecan (Enhertu), which is a type of drug called an antibody-drug conjugate, Dr. Strickler explained.

If these could be used after a recurrence to delay chemotherapy even further for these patients, “that could give them more options and better quality of life,” he said.

Extrachromosomal DNA promotes aggressiveness of small cell lung cancer


Researchers from CCR have discovered that extrachromosomal DNA — small particles of DNA that exist outside of chromosomes — can intensify tumor cell diversity and aggressiveness. The finding, published January 30, 2023, in Cancer Discovery

, helps explain how tumor cells can take on different characteristics, even within the same patient, that make the cancer more difficult to treat.

Typically, two chromosome copies are divided equally into each new cell during cell division, but ecDNA can segregate unequally, explains Anish Thomas, M.D., MBBS, Lasker Clinical Research Scholar in the Developmental Therapeutics Branch. Thus, one daughter cell can get more copies of the ecDNA than the other.

It was this trait that made ecDNAs intriguing to Thomas, whose group studies small cell lung cancer (SCLC), an aggressive form of lung cancer marked by resistance to chemotherapy and poor patient prognosis. Postdoctoral fellow Lorinc S. Pongor, Ph.D., had observed that certain SCLC cells contained abundant copies of a cancer-associated gene called MYC, which acts like a volume control for a broad range of genes that regulate tumor growth.

In collaboration with research biologist Darawalee Wangsa, Ph.D., and Thomas Ried, M.D., Senior Investigator in the Genetics Branch, the team confirmed that the extra copies of MYC in SCLC were housed outside the chromosome in ecDNA. They also found that the most common gene rearrangement in SCLC, called an RLF-MYCL fusion, is housed on ecDNA.

To investigate further, the researchers developed a non-invasive method to identify the presence of ecDNA in the blood plasma of patients with SCLC. They then looked at the number of MYC copies in multiple tumors from a patient with detectable ecDNA shortly after the patient passed away.

The patient’s tumor cells from different metastatic sites varied in their ecDNA content. Importantly, the tumor cells that had evolved into a more aggressive cell type contained ecDNA that allowed for many extra copies of MYC.

The researchers next step is to decipher how these genetic factors work together with the tumor’s environment to influence tumor cell aggressiveness. They also plan to investigate how ecDNAs might actively drive tumor metastasis in SCLC, with a continued focus on the amount of MYC in cells.

Thomashopes that their non-invasive detection of tumor ecDNA can one day be used to identify patients who are more likely to develop aggressive disease. While this is the first study to describe ecDNAs in SCLC, “fundamentally, it provides more insight into how tumors become diverse and aggressive, and how a single treatment might not be effective at hitting all the different types of tumor cells,” Thomas says.

Cannabis May Interfere With Pregnancy


Retrospective study finds exposure linked with higher rates of stillbirth, hypertensive disorders

Adverse outcomes in pregnancy appeared more frequent if the child-to-be was exposed to cannabis in the early stages of pregnancy, retrospective data from a multicenter study suggested.

Of more than 9,000 pregnancies, the primary composite endpoint of small for gestational age, medically indicated preterm birth, stillbirth, or hypertensive disorders of pregnancy occurred in 27.4% of the cannabis-exposed group compared with 18.1% of the non-exposed group (P<0.001), reported Torri Metz, MD, MS, of the University of Utah in Salt Lake City, at the Society for Maternal-Fetal Medicineopens in a new tab or window Annual Pregnancy Meeting.

The study was ancillary to a prospective nulliparous cohort study involving women recruited at eight U.S. centers from 2010 to 2013, and used frozen urine samples collected at 6 to 14 weeks’ gestation to examine exposure to cannabis.

“We wanted to look specifically at cannabis use early in pregnancy because that’s when the placenta is forming, and a lot of information we currently have indicates that cannabis use does affect the placenta,” said Metz. “With recreational marijuana use becoming legal in more states, we need better data because patients are interested in understanding the risk of cannabis use in pregnancy so they can make an informed decision.”

Metz explained that the natural endocannabinoid system regulates placenta development, raising concerns that the addition of cannabis could compromise that highly regulated system.

Among the individual components of the primary endpoint, most were significantly worse among the group exposed to cannabis:

  • Small for gestational age: 9.5% vs 4.1% (P<0.001)
  • Hypertensive disorders of pregnancy: 15.9% vs 13% (P=0.049)
  • Stillbirth: 1.5% vs 0.5% (P=0.003)
  • Medically indicated preterm birth: 5.2% vs 3.9% (P=0.141)

According to the National Conference on State Legislaturesopens in a new tab or window, 37 states have legalized marijuana for medical purposes and 21 states have legalized it for recreational use.

Based on the findings of the study, “clinicians should counsel their patients that marijuana use should be discontinued during pregnancy,” Cornelia Graves, MD, medical director of Tennessee Maternal Fetal Medicine and co-director of the Collaborative Perinatal Cardiac Center at the University of Tennessee in Nashville, told MedPage Today. “Patients should also be counseled that early use may increase their risk of pregnancy complications.”

“It should be noted that the counseling for marijuana use in pregnancy is the same counseling as we currently use for tobacco use in pregnancy — cessation is recommended in order to prevent poor pregnancy outcomes,” added Graves, who was not involved with the study.

Metz noted that most of the women in the study had smoked marijuana or other cannabis products, since cannabis edibles had not penetrated much of the market during the time frame that the frozen urine samples had been collected.

She and her colleagues accessed the data collected in the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2bopens in a new tab or window). Exposure to cannabis was ascertained by urine immunoassay for 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH), and positive results were confirmed with liquid chromatography tandem mass spectrometry.

Of the 10,038 participants in the trial, the researchers included data from 8,717 women unexposed to cannabis and 540 women whose urine indicated exposure during their first clinic visit.

The women who were exposed to cannabis tended to be younger — only 8% were over age 30 when giving birth, compared with 37% of the women who were not showing signs of cannabis exposure; those exposed were also more likely to be non-Hispanic Black, single and never married, and to have public insurance coverage.

The link between our food, gut microbiome and depression


A new study takes an important step forward in understanding the relationship of gut bacteria to what we eat and how we feel

Research has long suggested a link between our diet and our mental health. The gut microbiome — the collective genome of trillions of bacteria that live in the intestinal tract that are created largely by what we eat and drink — appears to influence our mood and mind-set.

But human studies large enough to pinpoint what bacteria matter, if they matter at all, have been missing.

That’s slowly changing. The largest analysis of depression and the gut microbiome to date, published in December, found several types of bacteria notably increased or decreased in people with symptoms of depression.

“This study provides some real-life evidence that you are what you eat,” says study author Andre Uitterlinden, who researches genetics at Erasmus Medical Centre in Rotterdam, Netherlands.

Or to be exact, how you feel is closely related to what you consume.

The gut-brain axis

The gastrointestinal system has been featured in brain research for centuries. In the early 1800s, John Abernethy, a popular London physician, held that “gastric derangement” was the root of all mental disorders.

And gastrointestinal symptoms often are reported in people with psychiatric illness. Weight and appetite changes are common among people with depression, from adolescence to older age. Anxiety has been tied to a heightened risk of nausea, heartburn, diarrhea and constipation. The link between food and mood is there even when we reach for macaroni and cheese to comfort us during a stressful time.

Interest in the gut-brain axis has had a resurgence in the past 20 years. A host of studies has pointed to a connection between the microbiota living in our intestinal tract, and our minds, including our memory, mood and cognitive skills.

Such research has spawned an industry of probiotics, prebiotics and fermented everything. Scientific names like bacteroidetes and lactobacillus, two of the most common bacteria found in healthy humans, have become household terms.

The best foods to feed your gut microbiome

The health trend has gotten a bit ahead of the evidence. Most of the studies linking depression and the gut, for example, have been in animals and studies involving human participants have been small.

Still, the evidence thus far shows a link between the two. In one noteworthy study, entitled “Transferring the Blues,” bacteria-free rats given fecal samples from humans diagnosed with major depression became anxious and disinterested in pleasurable activities. Their metabolism of tryptophan, a chemical connected to depression, changed. But the mechanics behind the microbe-mood pathway — and which bacteria matter — has been harder to uncover.

Bacteria that predict depressive symptoms

This new study moves that needle, largely because of its size. The investigators, led by Najaf Amin, who researches population health at Oxford University, analyzed data from the Rotterdam Study, a decades-long effort to understand the health of the local population.

Amin and her colleagues focused specifically on a phase of this study that included fecal sample collection from more than 1,000 individuals. These participants also provided a self-report on depression using a 20-item assessment.

The researchers parsed the data for associations between the bacteria populations in the fecal samples with scores from the depression assessment. They then conducted the same tests using data from another 1,539 Dutch citizens encompassing a range of ethnicities. (Validating the findings from one large group in a second large group makes them particularly reliable.)

The analysis revealed 16 types of bacteria that the authors called “important predictors” of depressive symptoms to varying degrees. For example, the study, published in Nature Communications, found a depletion of Eubacterium ventriosum among people who were depressed. Interestingly, this same decrease has been spotted in microbiome studies of traumatic brain injury and obesity, both of which are tied to depression, supporting the notion that this species of bacteria has something to do with this mood disorder.

Immigrants arrive with flourishing gut microbes. Then America’s diet trashes them.

The study authors also took a stab at answering the big question: Do any particular gut flora cause depression? It’s a tricky proposition. Major depression disorder has been linked to more than 80 different genetic mutations and all of these connections are weak.

“There’s no gene that causes depression,” said Jane Foster, professor of psychiatry at UT Southwestern, who studies the gut-brain connection and was not involved with this study.

Technology to clearly establish causation does not exist. So the researchers turned to a crafty statistical calculation known as Mendelian randomization, which can tease out the direction of an influence when the gene-disease connection is strong. That’s not the case with depression, which makes the calculation here interesting but not necessarily useful.

Still, the calculation did point to an abundance of one bacteria — Eggerthella — in people with depression as a possible cause of depressive symptoms. The finding didn’t surprise Amin.

Eggerthella, she notes, “is found to be consistently increased in abundance in the guts of depressed individuals.” The result provides evidence that changes in the gut flora may trigger depressive symptoms. “We cannot exclude our own DNA as a contributing source,” Foster said. “It’s a combination of the DNA you were born with, your experiences in life to date, and your environment.”

Whether the flora cause the depression or vice versa may be beside the point. “Causation isn’t a one-way street,” said Jack Gilbert, who directs the Microbiome and Metagenomics Center at the University of California at San Diego, and was not involved with the new study.

Rather, the gut and brain cycle together. For instance, it appears that comfort eating after a stressful event can change the microbial community in our intestines, which in turn exacerbates depressed feelings.

What is clear, Gilbert said, is that when we are depressed, the gut microbiome is often missing beneficial flora. “If we can add those elements back in,” Gilbert said, “maybe we can re-energize that cycle.”

Changing your diet to improve your mood

This is where diet enters the picture. An individual who does not consume enough fiber, for example, may experience a decrease in butyrate-producing bacteria, Amin said, leading to stress and inflammation and, potentially, symptoms of depression.

It may feel like a letdown that the message from all this work is to eat plenty of fruits and vegetables and not so much excess sugar. But the sheer amount of research confirming the power of a healthy gut has become undeniable for even the most hard-bitten skeptic, Gilbert included.

“When the evidence points to the fact that eating healthy, doing a little bit of exercise and taking mindfulness breaks can have benefits, we should probably listen to that data,” he says.

Eating fiber alters the microbiome. It may boost cancer treatment, too.

Research is slowly illuminating exactly how bacteria talk to the brain. For example, many of them produce short-chain fatty acids such as butyrate and acetate, which influence brain activity. Others generate a chemical called GABA, deficits of which are linked to depression.

This progress means that diet may not be the only way to improve our gut colonies. The use of probiotics to prevent and treat depression could become more of an exact science, leading eventually to effective alternatives to antidepressants, which, Gilbert points out, still carry a stigma in many communities.

And profiling the bacteria could help identify people at risk for depression, notes Foster. Her lab is searching for signs among gut flora indicating what drug is most likely to benefit someone suffering from depression.

All this research has convinced Uitterlinden that adopting a gut-improving diet comes with just one significant side effect. “You’ll get happier,” he said.

Study finds mushrooms magnify memory by boosting nerve growth


Researchers found lion’s mane mushroom improved brain cell growth and memory in pre-clinical trials. Credit: UQ

Researchers from The University of Queensland have discovered the active compound from an edible mushroom that boosts nerve growth and enhances memory.

Professor Frederic Meunier from the Queensland Brain Institute said the team had identified new active compounds from the mushroom, Hericium erinaceus.

“Extracts from these so-called ‘lion’s mane’ mushrooms have been used in traditional medicine in Asian countries for centuries, but we wanted to scientifically determine their potential effect on brain cells,” Professor Meunier said.

“Pre-clinical testing found the lion’s mane mushroom had a significant impact on the growth of brain cells and improving memory.

“Laboratory tests measured the neurotrophic effects of compounds isolated from Hericium erinaceus on cultured brain cells, and surprisingly we found that the active compounds promote neuron projections, extending and connecting to other neurons.

“Using super-resolution microscopy, we found the mushroom extract and its active components largely increase the size of growth cones, which are particularly important for brain cells to sense their environment and establish new connections with other neurons in the brain.” Graphical abstract. Credit: Journal of Neurochemistry (2023). DOI: 10.1111/jnc.15767

Co-author, UQ’s Dr. Ramon Martinez-Marmol said the discovery had applications that could treat and protect against neurodegenerative cognitive disorders such as Alzheimer’s disease.

“Our idea was to identify bioactive compounds from natural sources that could reach the brain and regulate the growth of neurons, resulting in improved memory formation,” Dr. Martinez-Marmol said.

Dr. Dae Hee Lee from CNGBio Co, which has supported and collaborated on the research project, said the properties of lion’s mane mushrooms had been used to treat ailments and maintain health in traditional Chinese medicine since antiquity.

“This important research is unraveling the molecular mechanism of lion’s mane mushroom compounds and their effects on brain function, particularly memory,” Dr. Lee said.

Diabetes: Add These Drinks To Your Diet To Better Manage Blood Sugar Levels


Read on for a list of simple drinks that can help control blood sugar levels.

Diabetes: Add These Drinks To Your Diet To Better Manage Blood Sugar Levels

A green smoothie can help manage your diabetes and will also boost your overall health

Diabetes and prediabetes are linked to hyperglycemia, sometimes referred to as high blood sugar. When your blood sugar level is high but not high enough to be diagnosed as diabetes, you have prediabetes. The hormone insulin, which enables your cells to use the blood sugar that is circulating, is typically produced by your body to control your blood sugar levels. As a result, insulin is crucial in controlling blood sugar levels. 

Yet, a number of circumstances can impede the control of blood sugar and result in hyperglycemia. When your liver creates too much glucose, your body produces too little insulin, or your body cannot efficiently utilise insulin, these internal factors can contribute to high blood sugar levels. Insulin resistance is the name given to the latter. Continue reading as we share some early-to-make drinks that will help manage blood sugar levels. 

Try these drinks to improve your blood sugar levels:

1. Chamomile tea

Many illnesses have long been treated with chamomile tea. It has antioxidant and cancer-preventive characteristics, and a recent study indicated that it might also help you control your blood sugar levels. Drinking  one cup of chamomile tea after meals can help reduce blood sugar, insulin, and insulin resistance according studies. 

2. Vegetable juice

Since the majority of 100% fruit juices include 100% sugar, you can try tomato juice or a veggie juice substitute. For a tasty supply of vitamins and minerals, create your own combination of green leafy vegetables, celery, or cucumbers with a few berries. Do not forget to include the berries in your daily carbohydrate intake.

3. Kombucha

A fermented beverage called kombucha is often produced from black or green tea. It’s a fantastic source of probiotics, a class of healthy bacteria found in the stomach that has been thoroughly researched for its capacity to enhance blood sugar regulation. 

4. Green smoothie

Green smoothies are a great way to add more fibre and nutrients to your diet while maintaining your hydration. To create a nutritious, homemade smoothie, try combining green veggies like spinach, kale, or celery along with some protein powder and some fruit. Fruits should be included in your daily carbohydrate intake because they contain carbs.

5. Coffee (without sugar)

By enhancing sugar metabolism, coffee may help reduce your chance of developing type 2 diabetes. It’s crucial that your coffee be unsweetened, just like with tea. Coffee with milk, cream, or sugar has more calories overall and could have an impact on your blood sugar levels. You have a lot of options for low- or no-calorie sweeteners if you decide to use them.

6. Low-fat milk

Milk does add carbohydrates to your diet, but it also contains significant amounts of vitamins and minerals. Limit your intake of milk to no more than two to three 8-ounce glasses each day, and always choose unsweetened, low-fat, or skim varieties.

7. Turmeric water/milk

Curcumin, a compound in this golden spice, may help maintain the function of your pancreas and stop prediabetes from developing into Type 2 diabetes. The use of turmeric can help the body become more sensitive to the effects of insulin. 

Incorporate these simple drinks to your routine if you are struggling with high blood sugar levels. 

21 Powerful Bruce Lee Quotes That Will Ignite The Fire In Your Soul


Most Inspiring Bruce Lee Quotes

Bruce Lee means self-disciple. Bruce Lee means focus. Bruce Lee means determination, Bruce Lee means victory. The man has played so many roles in his one lifetime. Whatever he did, he redefined it and took it to an ideal level. During his lifetime he wore the crown of being one the most brilliant martial artist, a famous action star, and a philosopher as well.

Here are some of the great insights arising from the beautiful life he led and also showing us how to live one as well.

Most Inspiring Bruce Lee Quotes© Muscle & Fitness

Most Inspiring Bruce Lee Quotes© Nerdist

Most Inspiring Bruce Lee Quotes© brucelee

Most Inspiring Bruce Lee Quotes© visitseattle

Most Inspiring Bruce Lee Quotes© insidehoops

Most Inspiring Bruce Lee Quotes© Kung-fu Kingdom

Most Inspiring Bruce Lee Quotes© Muscle & Fitness

Most Inspiring Bruce Lee Quotes© Nerdist

Most Inspiring Bruce Lee Quotes© brucelee

Most Inspiring Bruce Lee Quotes© visitseattle

Most Inspiring Bruce Lee Quotes© insidehoops

Most Inspiring Bruce Lee Quotes© Kung-fu Kingdom

Most Inspiring Bruce Lee Quotes© Muscle & Fitness

Most Inspiring Bruce Lee Quotes© Nerdist

Most Inspiring Bruce Lee Quotes© brucelee

Most Inspiring Bruce Lee Quotes© visitseattle

Most Inspiring Bruce Lee Quotes© insidehoops

Most Inspiring Bruce Lee Quotes© Kung-fu Kingdom

Most Inspiring Bruce Lee Quotes© Muscle & Fitness

Most Inspiring Bruce Lee Quotes© Nerdist

Most Inspiring Bruce Lee Quotes© brucelee